IRT Benchmarking & Market Dynamics (4th Ed.)
$6,750.00 – $13,500.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
The Interactive Response Technology (IRT) space, also sometimes called Randomization and Trial Supply Management (RTSM), has continued to evolve since Industry Standard Research put out our first report on the topic in 2014. Over the years, clinical technologies have been driven by the need to integrate, yielding a landscape of integrated technology providers and full-service CROs that offer IRT as part of a suite of other technologies. There are few dedicated IRT providers left among the market leaders, and customers continue to value integration with EDC, CTMS, eCOA, and other technologies above all else.
The clinical technology industry continues to see a lot of change, including mergers, acquisitions, and spin-offs among leaders in the space. Furthermore, decentralized trials have disrupted traditional clinical trial methods, challenging IRT providers to support direct to patient shipping and other unmet needs. Amidst all of the upheaval, ISR aims to stay abreast of the latest trends in clinical technology and to keep a pulse on outsourcing trends and provider performance.
This report digs into the IRT provider evaluation process, including which criteria are most important for choosing a provider, the role of build complexity in provider selection, and critical quality measures for IRT systems. Also included is an overview of outsourcing trends, such as usage of preferred provider agreements, how rates of outsourcing to third party providers differ across company sizes, suggested improvements to IRT systems from users, and unmet needs in decentralized trials. In keeping with the benchmarking methodology used across many of ISR’s reports, this report includes an analysis of key metrics of brand strength, a metric based on pure perception in the marketplace, as well as brand performance, which is based on respondent evaluations of their recent interactions with service providers.
What you will learn:
Pharmaceutical, Biopharma, or Biotech Sponsor Organizations and CROs:
- Learn which IRT solutions are being utilized most by your peers
- Understand which providers are performing well against 17 key criteria and might be a good fit for your studies
- Learn how others in the outsourcing community are evaluating and maintaining relationships with their favorite providers
IRT Service Providers:
- Understand the importance sponsors place on various service attributes and technical capabilities when selecting an IRT solution
- Understand how your brand is perceived in the marketplace
- Benchmark your performance against 21 service providers across 17 attributes based on the experience of real users in the IRT outsourcing community
- Read verbatim responses to understand why respondents prefer specific solutions, what improvements they would like to see in future versions of IRT, and what suggestions they have for supporting decentralized trials
Major Topics:
- IRT Provider Selection Process
- Outsourcing Trends
- IRT Provider Perceptions
- IRT Provider Performance
- Company Service Quality Profiles
- Study Data